Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.

Viatour P, Merville MP, Bours V, Chariot A.

Trends Biochem Sci. 2005 Jan;30(1):43-52. Review.

2.

Regulation and function of IKK and IKK-related kinases.

Häcker H, Karin M.

Sci STKE. 2006 Oct 17;2006(357):re13. Review.

PMID:
17047224
3.

The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.

Rothwarf DM, Karin M.

Sci STKE. 1999 Oct 26;1999(5):RE1. Review.

PMID:
11865184
4.

[NF-kappaB tumorigenesis and drug developement].

Liu WF, Yu SS, Li YZ.

Sheng Wu Gong Cheng Xue Bao. 2005 Jan;21(1):12-8. Review. Chinese.

PMID:
15859322
5.

IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.

Schmid JA, Birbach A.

Cytokine Growth Factor Rev. 2008 Apr;19(2):157-65. doi: 10.1016/j.cytogfr.2008.01.006. Epub 2008 Mar 4. Review.

PMID:
18308615
6.

NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?

Jones WK, Brown M, Ren X, He S, McGuinness M.

Cardiovasc Toxicol. 2003;3(3):229-54. Review.

PMID:
14555789
7.

NF-kappaB as a therapeutic target in chronic inflammation: recent advances.

Makarov SS.

Mol Med Today. 2000 Nov;6(11):441-8. Review.

PMID:
11074370
8.

Regulation of the immune system by NF-kappaB and IkappaB.

Liou HC.

J Biochem Mol Biol. 2002 Nov 30;35(6):537-46. Review.

PMID:
12470586
9.

Beyond IkappaBs: alternative regulation of NF-kappaB activity.

Neumann M, Naumann M.

FASEB J. 2007 Sep;21(11):2642-54. Epub 2007 Apr 12. Review.

PMID:
17431096
10.

Reprogramming RelA.

Campbell KJ, Perkins ND.

Cell Cycle. 2004 Jul;3(7):869-72. Epub 2004 Jul 4. Review.

PMID:
15190199
11.

Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.

Epinat JC, Gilmore TD.

Oncogene. 1999 Nov 22;18(49):6896-909. Review.

12.

I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations.

Schmitz ML, Bacher S, Kracht M.

Trends Biochem Sci. 2001 Mar;26(3):186-90. Review.

PMID:
11246025
13.
14.

Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies.

Panwalkar A, Verstovsek S, Giles F.

Cancer. 2004 Apr 15;100(8):1578-89. Review.

15.

NF-kappaB as a therapeutic target in cancer.

Orlowski RZ, Baldwin AS Jr.

Trends Mol Med. 2002 Aug;8(8):385-9. Review.

PMID:
12127724
16.

Deregulation of NF-kappaB and its upstream kinases in cancer.

Sun SC, Xiao G.

Cancer Metastasis Rev. 2003 Dec;22(4):405-22. Review.

PMID:
12884915
17.

NF-kappaB: a multifaceted transcription factor regulated at several levels.

Schmitz ML, Mattioli I, Buss H, Kracht M.

Chembiochem. 2004 Oct 4;5(10):1348-58. Review.

PMID:
15457532
18.

Nuclear transcription factor NF-kappa B: role in biology and medicine.

Aggarwal BB, Takada Y, Shishodia S, Gutierrez AM, Oommen OV, Ichikawa H, Baba Y, Kumar A.

Indian J Exp Biol. 2004 Apr;42(4):341-53. Review.

PMID:
15088683
19.

NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia.

Breccia M, Alimena G.

Expert Opin Ther Targets. 2010 Nov;14(11):1157-76. doi: 10.1517/14728222.2010.522570. Review.

PMID:
20858024
20.

T-cell-receptor- and B-cell-receptor-mediated activation of NF-kappaB in lymphocytes.

Weil R, Israël A.

Curr Opin Immunol. 2004 Jun;16(3):374-81. Review.

PMID:
15134788

Supplemental Content

Support Center